LCM
DNTH icon

Laurion Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Laurion Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,536
Closed -$766K – 609
2024
Q1 		$766K Sell
25,536
-731
-3% -$15.9K 0.01% 400
2023
Q4 		$273K Sell
26,267
-10,126
-28% -$112K ﹤0.01% 418
2023
Q3 		$497K Sell
36,393
-1
-0% -$13 ﹤0.01% 393
2023
Q2 		$441K Hold
36,394
– – ﹤0.01% 431
2023
Q1 		$463K Hold
36,394
– – ﹤0.01% 347
2022
Q4 		$230K Hold
36,394
– – ﹤0.01% 379
2022
Q3 		$821K Hold
36,394
– – ﹤0.01% 377
2022
Q2 		$699K Buy
+36,394
New +$900K 0.01% 315
2020
Q3 		– Sell
-2,787
Closed -$334K – 904
2020
Q2 		$334K Buy
+2,787
New +$393K ﹤0.01% 705
2019
Q4 		– Sell
-6,014
Closed -$987K – 961
2019
Q3 		$987K Sell
6,014
-2,958
-33% -$562K 0.01% 644
2019
Q2 		$2.12M Buy
8,972
+8,282
+1,200% +$2.05M 0.02% 368
2019
Q1 		$182K Sell
690
-10,750
-94% -$1.85M ﹤0.01% 754
2018
Q4 		$1.04M Sell
11,440
-6,318
-36% -$861K 0.02% 549
2018
Q3 		$3.41M Sell
17,758
-4,117
-19% -$866K 0.03% 441
2018
Q2 		$4.72M Buy
+21,875
New +$4.94M 0.04% 365

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Laurion Capital Management's DNTH Position: Q2 2024 in Review

Laurion Capital Management sold out of Dianthus Therapeutics (DNTH) in Q2 2024, closing a stake of 25,536 shares — an estimated $766K sold.

Laurion Capital Management first reported a position in DNTH in Q2 2018 and held it in 15 quarters. The position peaked at $4.72M in Q2 2018. 74 funds tracked by Wall St. Rank hold DNTH as of Q2 2024.

  • Laurion Capital Management reported no remaining Dianthus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Laurion Capital Management sold 25,536 Dianthus Therapeutics shares in Q2 2024, an estimated $766K.
  • Laurion Capital Management first reported a position in Dianthus Therapeutics in Q2 2018 and held it in 15 quarters.
  • Laurion Capital Management's Dianthus Therapeutics position peaked at $4.72M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2024.

Based on Laurion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.